Takeda Pharmaceutical Company Limited
TAK
|
News
|
$13.215
-1.23%
420K
|
Health Technology
(0.0% 1d) (-5.7% 1m) (-20.9% 1y) (0.0% 2d) (-0.1% 3d) (1.5% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 41,823,065,245
http://www.takeda.co.jp
Sec Filling | Patents | 47495 employees
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
diagnostics qdenga dengue vaccine
add to watch list Paper trade email alert is off
Press-releases
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
granted approval cancer treatment for
Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
NBIX | News M | $138.63 -1.04% 450K
|
Health Technology
|
| O: 5.49%
H: 2.84%
C: -0.65%
nbi-1065 positive for
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Published: 2024-04-22 (Crawled : 09:00) - prnewswire.com
SMFNF | News | $55.63 24K
|
Finance
|
| O: -0.16%
H: 3.14%
C: 0.04%
ALPMY | News | $9.49 480K
|
Manufacturing
|
| O: 0.63%
H: 0.0%
C: -0.31%
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: 0.8%
H: 0.75%
C: 0.38%
drug company for agreement
Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 02:00) - prnewswire.com
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MIRM | $24.1 -1.31% 120K
|
Health Technology
|
| O: -0.68%
H: 2.52%
C: 1.71%
report million reach treatment market
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published: 2024-04-18 (Crawled : 23:00) - biospace.com/
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
entyvio fda disease active for therapy
Neurvati Neurosciences Announces Appointment of Deborah Dunsire, MD, as Member and Chair of Company Board of Directors
Published: 2024-04-15 (Crawled : 12:00) - prnewswire.com
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: -1.19%
H: 0.26%
C: -0.98%
company
Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Published: 2024-03-26 (Crawled : 18:00) - biospace.com/
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: 1.84%
H: 0.24%
C: -0.14%
adzynma japan takeda approval injection
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: -0.96%
CNTG | $0.475 -1.04% 15K
|
Commercial Services
|
| O: 1.43%
H: 1.41%
C: -1.41%
partnership genetic takeda disorders
Takeda Announces U.S. FDA Approval of Supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) in Adult Patients with Newly Diagnosed Ph+ ALL
Published: 2024-03-19 (Crawled : 17:00) - biospace.com/
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: -0.96%
iclusig fda drug takeda approval application
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: 0.21%
H: 0.97%
C: 0.7%
NVS | News | $98.1 0.84% 1.3M
|
Health Technology
|
| O: 0.05%
H: 0.14%
C: -0.93%
JNJ | News | $148.515 -0.7% 4.3M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
LLY | News | $735.1 -1.42% 1.2M
|
Health Technology
|
| O: -0.7%
H: 0.73%
C: -0.16%
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
REGN | News | $909.39 0.23% 210K
|
Health Technology
|
| O: -0.27%
H: 1.26%
C: 0.84%
AMGN | News | $274.15 0.22% 900K
|
Health Technology
|
| O: 0.2%
H: 1.14%
C: -1.18%
antibody therapeutics market
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 58% | 42% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
RBBN 4 | $3.29 28.02% 2.2M
|
Electronic Technology
Last 48 Hours Insiders Buying
NWFL | News | $24.0 -0.46% 4.6K
|
Finance
|
17:00
MNSB P 310 | $15.91 -2.75% 18K
|
Finance
|
15:30
TPL P 3 | $585.605 -0.38% 11K
|
Miscellaneous
|
15:01
ISBA P 966 | $18.0001 3.1K
|
Finance and Insurance
|
15:01
MEGI | $11.98 74K
|
|
00:30
CTRN P 29000 | $21.855 -1.69% 26K
|
Retail Trade
|
22:00
CONN | $3.735 0.95% 23K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.685 6.6K
|
Utilities
|
18:30
CMTV P 700 | $16.59 1K
|
Finance and Insurance
|
18:30
FNB | $13.625 -0.04% 700K
|
Finance
|
17:30
RMCF | $3.54 7K
|
Consumer Non-Durables
|
20:10